4//SEC Filing
Tsai Benjamin 4
Accession 0001209191-21-039338
CIK 0001720725other
Filed
Jun 8, 8:00 PM ET
Accepted
Jun 9, 8:48 PM ET
Size
7.7 KB
Accession
0001209191-21-039338
Insider Transaction Report
Form 4
Tsai Benjamin
Director
Transactions
- Award
Common Stock
2021-06-07+3,466→ 10,066 total - Award
Stock Option (Right to Buy)
2021-06-07+5,199→ 5,199 totalExercise: $17.74Exp: 2031-06-06→ Common Stock (5,199 underlying)
Footnotes (3)
- [F1]Represents a grant of restricted stock units (the "RSUs"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer.
- [F2]The shares underlying the RSU will vest on June 7, 2022, but will vest fully on the date of the next annual stockholder meeting held after the date of grant if not fully vested on such date, in each case, subject to the Reporting Person's continuous service to the Issuer as a director through each such date.
- [F3]The shares underlying the option vest as to one-twelfth (1/12th) of the shares on July 7, 2021 and monthly thereafter on the same day of the month as the grant date, in each case, subject to the Reporting Person's continuous service to the Issuer as a director through each such date.
Documents
Issuer
Oyster Point Pharma, Inc.
CIK 0001720725
Entity typeother
Related Parties
1- filerCIK 0001791247
Filing Metadata
- Form type
- 4
- Filed
- Jun 8, 8:00 PM ET
- Accepted
- Jun 9, 8:48 PM ET
- Size
- 7.7 KB